Brand : hepcvir
Composition : Sofosbuvir
Packing : 28 tablets
Strength : 400mg
Manufactured : cipla .
hepcvir is an active chemical component which is applicable in various brands.
hepcvir is a nucleotide prodrug analogue;
it is a NS5B polymerase inhibitor with HCV prohibiting activity.
hepcvir is available in the strength of 400mg and the dosage form of hepcvir is film coated tablet
hepcvir is not monotherapy; it should be combined with other retroviral medicines. The therapy should be followed for 12 weeks which results as curable
hepcvir has prominent anti viral activity, which used to treats chronic hepatitis C viral infection.
It is effective against hepatitis C of I, II, III and IV genotypes.
In hepatitis c treatment, monotherapy is not suggested, it is combinational therapy
The schedule and duration of the therapy should be depending upon the type of genotype of the virus and patient’s level.
The efficacy of the treatment depends on the virus and host characterization.
hepcvir mechanism of action
hepcvir, an anti-viral medicine has nucleotide prodrug that prevents the replication of hepatitis C virus by prohibiting the effect of HCV NS5B RNA polymerase.
produce GS-461203, and form pharmacologically active triphosphate. uridine This enzyme go through intercellular metabolism to
Hepatitis C virus NS5B RNA polymerase infused this metabolite into viral DNA, it acts as chain end.
hepcvir is absorbed rapidly after oral administration
The peak plasma concentration of hepcvir and circulating metabolite GS-331007 occurs at 0.5 to 2 hours and 2 to 4 hours respectively after administration
hepcvir with high fat meals, causes reduction in absorption
rate of the hepcvir when compared with fasting
Whereas high fat meals do not creates effect when exposed to metabolite GS-331007. So it is not consider whether hepcvir takes with or without food
hepcvir is highly bound to blood plasma protein approximately 61-65%. The GS-331007 binding to plasma proteins is minimal.
hepcvir is highly metabolized in liver and to form
nucleoside triphosphate analogue
which is active (GS-461203).
The activation metabolic of route is associates sequential hydrolysis of a carboxylic acid ester molecule with cathepsin A or carboxyl esterase 1.
The elimination of route in metabolites occurs
via Kidneys, intestines, and lungs
The drug around 78% excreted as inactive metabolite, 3.5% was excreted as hepcvir
The half life time of both hepcvir and GS-331007 is 0.4 and 27 hours respectively.
In the treatment of chronic hepatitis C infection;
hepcvir should be combined with ribavirin or pegylated interferon and ribavirin. Combinational therapy: The usual prescribed dose of hepcvir is one tablet 400mg should be taken as a single dose, disregarding of food intake.
HCG (genotype I and IV: hepcvir + peg interferon alfa + ribavirin followed for 12 weeks
HCG genotype II: hepcvir + ribavirin for 12 weeks HCG genotype III: hepcvir + ribavirin for 24 weeks Ribavirin dose should be recommended on the basis of weight of the patient. It is administered orally with food.
In the condition of renal failure, ribavirin should be discontinued. There is a chance to get re-infection of HCV after transplantation; in this condition hepcvir with ribavirin is recommended it is not more than 48 weeks.
Peg interferon dosage regimen: for
Peg interferon alpha 2a: 180 mcg SC weekly Peg interferon alpha 2b: 1.5mcg/kg/week SC, not exceed to 150mcg/week
Ribavirin dosage regimen: for
For prevention of post transplant HCV re-infection: hepcvir + ribavirin for 48 weeks or until liver transplant.
It should be taken with food
<75 kg: 500mg PO twice daily, ≥75 kg: 600mg PO twice daily
For hepatitis C viral infection
<12 years or <35 kg: the safety and efficacy of the drug has not been established
≥12 years or weight ≥35 kg: 400mg PO qDay with weight based ribavirin
During combination with ribavirin, it must be taken with food. hepcvir should be taken with or without food
symptomatic bradycardia occurs while taking hepcvir with amiodarone.
This combination causes serious cardiac arrest.
Some other drugs like;
symptomatic bradycardia occurs while taking hepcvir with amiodarone. This combination causes serious cardiac arrest. Some other drugs like;
Atazanavir; cobicistat: cobicistat is an inhibitor of transporters P-glycoprotein inducers and BCRP. In combination with hepcvir leads to increase its concentration; adverse affects may produce.
Apalutamide is a P-glycoprotein inducers and BCRP. It should not be combined with hepcvir, these concomitant can cause reduction of plasma concentration of hepcvir and loss of anti-viral efficacy.
While using combinational therapy there is a possibilities of contraindication;
Autoimmune hepatitis, decompensated liver disease For neonates and infants
Drugs like rifampin and st. John s wort are potent
P-gp inducers leads to reduce plasma concentration of hepcvir.
Caution in renal impairment patient
Flu like symptoms
Pregnant women or become pregnant
Pancreatitis, Thalassemia major, sickle cell anemia Concomitant with Didanosine
Autoimmune hepatitis, decompensated liver disease, For neonates and infants
While combined with ribavirin care should be taken, because it causes fetal harm or death. Ribavirin not recommended in pregnancy period.
Hemolytic anemia, Anemia, Ocular disorders, Carcinogenic effects, Bone marrow suppression
<1% has chances to get;
Some healthcare professionals;
Both ribavirin and peg interferon has some adverse effects;
Based on pharmacological effects;
>10% of the patient may have chance to get adverse effects while taking hepcvir and ribavirin (12 weeks) like;
Nausea, Insomnia, Pruritus, Fatigue, Headache,
Myalgia, arthralgia, muscle pain, back pain, muscle spasm, increased creatine kinase
Increases lipase, nausea, diarrhea, vomiting, abdominal discomfort, constipation, dyspepsia, dry mouth, gastro esophageal reflux
Decreased hemoglobulin, anemia, neutropenia, decreased neutrophils, decreased lymphocytes count, platelet counts, Pancytopenia
hepcvir is comes under the pregnancy category: B.
But when combined with ribavirin category should be X Ribavirin causes fetal death
Concomitant with ribavirin and peg interferon, it is not recommended in breastfeeding mothers.
hepcvir is generally stored at room temperature below 30°c (86°F)
It should be keep away from moisture, heat, and light
Keep reach out from children and pets
Once patient fail to administer the dose of hepcvir, must consult with medical
practitioner and take the missed dose. Otherwise it should be skipped and follow
the next drug schedule.
Do not double the dose.
sofosbuvir400mg.com is a fully licensed and regulated pharmacy, takes all precautions to strictly abide by
the laws and regulations set forth in the dispensing of prescription medications.
By placing the order for your prescription medicines, you acknowledge and accept
the following terms regarding the purchase of any prescription medicines.
sofosbuvir400mg.com will not dispense any prescription medication without a valid prescription from a licensed physician.
If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists
The drug information provided in the sofosbuvir400mg.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
sofosbuvir400mg.comrequires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from sofosbuvir400mg.com
sofosbuvir400mg.com is a Caregiver can order prescription medicines on your behalf..